All News

A phase 2 trial presented at the American Society of Hematology in December could pave the way for a second approval for Istodax (romidepsin).

Study shows experimental drug ponatinib acts against a mutation found in small percentage of chronic myeloid leukemia cases that is resistant to other forms of therapy

Treatment differs for Acute myeloid leukemia pediatric patients compared with older adults.

Chronic myeloid leukemia (CML)usually can be managed as a chronic disease by therapies, including Gleevec (imatinib) or two newer drugs, Sprycel (dasatinib) or Tasigna (nilotinib).

For Hodgkin lymphoma patients who progress after a stem cell transplant, two new treatments may bring new hope.

In recent years, scientists discovered that an enzyme called CYP2D6 could possibly predict whether a patient would respond to the drug. Small studies aimed at confirming the predictive link, however, have been consistently inconsistent.

Adding Afinitor, an mTOR inhibitor, to tamoxifen helped women with metastatic breast cancer live about four months longer without their disease getting worse, according to a study presented Thursday at SABCS.

After a diagnosis of stage 3 breast cancer at age 32, Moana Papa embraced advocacy, traveling from her home in New Zealand to the San Antonio Breast Cancer Symposium to bring information back to her community.

Obese women with breast cancer are at higher risk for recurrence and death, but new findings suggest it may depend on cancer subtype.